e-learning
resources
Virtual 2021
05.09.2021
Pulmonary embolism in non-COVID-19 and COVID-19 patients
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
A. Çimen (istanbul, Turkey), A. Kalpaklioglu (kirikkale, Turkey)
Source:
Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Session:
Pulmonary embolism in non-COVID-19 and COVID-19 patients
Session type:
E-poster
Number:
510
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Çimen (istanbul, Turkey), A. Kalpaklioglu (kirikkale, Turkey). Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism. 510
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Emerging classes of drugs for the treatment of obstructive lung disease
Eosinophils and airway nerves in asthma
Related content which might interest you:
The Importance of the local expression of acute phase reactants in the COPD
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Can we predict the massiveness of acute pulmonary embolism in stable patients?
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010
Comparison of local and systemic thrombolytic treatment for acute massive pulmonary embolism
Source: Eur Respir J 2007; 30: Suppl. 51, 544s
Year: 2007
Comparison of computed tomography features of acute phase of cardiogenic pulmonary edema and acute lung injury
Source: Annual Congress 2011 - Acute respiratory failure
Year: 2011
Treatment of acute pulmonary embolism
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014
Treatment of acute pulmonary embolism
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020
Treatment of acute pulmonary embolism
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017
Treatment of acute pulmonary embolism
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018
Assessing of the liver function tests in patients with acute pulmonary embolism
Source: Eur Respir J 2005; 26: Suppl. 49, 522s
Year: 2005
Can mean platelet volume be an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease?
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009
Time course of systemic inflammatory markers during acute exacerbation of COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 555s
Year: 2007
The rate of pulmonary thromboembolism in acute exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 297s
Year: 2005
How many patients recover from acute kidney injury after pulmonary embolism?
Source: Virtual Congress 2020 – Pulmonary embolism and beyond
Year: 2020
The challenge of acute exacerbation of pulmonary fibrosis
Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease
Year: 2014
Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Update on acute pulmonary embolism
Source: Eur Respir Rev 2009; 18: 137-147
Year: 2009
D-dimer testing in patients with acute exacerbation of COPD and suspected pulmonary embolism
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Assessment of myocardial injury in low-risk acute pulmonary embolism
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept